Trial Results on Vioxx Do Not Explain Mechanism Behind Adverse Events

"The reason for the increased risk of heart attack and stroke with the withdrawn arthritis drug rofecoxib (Vioxx) is a mystery neither the drug's maker Merck and Co. Inc. nor the U.S. Food and Drug Administration (FDA) has been able to explain."